‘New Drugs for Bad Bugs’ (ND4BB)

A specialist in therapeutic approaches to treat resistant bacterial infections, Mutabilis has been selected to join the European consortium ENABLE — aimed at developing antibiotics to tackle infections caused by multi-resistant gram-negative bacteriamore